POLYMORPHISM OF METHYLENETETRAHYDROFOLATE REDUCTASE (A1298C) AS A RISK FACTOR FOR OSTEOPOROSIS IN POST-MENOPAUSAL INDONESIAN WOMEN
Autor: | Tri Budi W. Rahardjo, Sri Sofiati Umami, Christopher J. Talbot, Lindawati S. Kusdhany, Elza Ibrahim Auerkari |
---|---|
Rok vydání: | 2017 |
Předmět: |
Pharmacology
Genetics Bone mineral medicine.medical_specialty biology Osteoporosis Pharmaceutical Science medicine.disease Allotype law.invention Endocrinology Polymorphism (computer science) law Internal medicine Methylenetetrahydrofolate reductase Genotype medicine biology.protein Pharmacology (medical) Risk factor Polymerase chain reaction |
Zdroj: | Asian Journal of Pharmaceutical and Clinical Research. 10:172 |
ISSN: | 2455-3891 0974-2441 |
DOI: | 10.22159/ajpcr.2017.v10i10.20272 |
Popis: | Objective: The study aimed to assess the association between the A1298C polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene and risk to osteoporosis in post-menopausal Indonesian women.Methods: After ethical approval, calcaneus bone mineral density (BMD) (T-scoring) was assessed from 194 consenting post-menopausal Indonesian women by dual-energy X-ray absorptiometry, and DNA of the participants was isolated from peripheral blood samples. To determine the status of A1298C polymorphism of MTHFR, isolated DNA was polymerase chain reaction (PCR) amplified in 35 cycles, to result in PCR product sizes of 302 bp (1298A) and 275 bp (1298C). For fragment detection, the PCR product was subjected to electrophoresis on agarose gel. The results were statistically assessed for genotype and allotype comparison according to the T-score grouping by Chi-square analysis, assuming statistical significance at p |
Databáze: | OpenAIRE |
Externí odkaz: |